Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cockroach non-desensitizing glutamate-gated chloride channel (GluCl) is a member of the Cys-loop ligand-gated ion channel superfamily, primarily found in the nervous system of invertebrates like Periplaneta americana (Raymond et al., 2000). Unlike many other ligand-gated channels, this specific subtype exhibits a characteristic lack of desensitization, allowing for sustained inhibitory chloride currents upon activation by the neurotransmitter L-glutamate (Zhao et al., 2004). It plays a vital role in regulating neuronal excitability and motor control in insects (Wolstenholme, 2012). Because GluCls are absent in vertebrates, they are highly effective targets for selective insecticides such as ivermectin and fipronil (He et al., 2016). These compounds disrupt the insect's nervous system by either locking the channel open or blocking the pore, resulting in rapid paralysis and death. The channel's unique physiological properties make it a cornerstone of modern pest management strategies. Research into its structure has facilitated the development of next-generation parasiticides with improved safety profiles. Resistance to these drugs often arises from specific mutations within the channel's pore-lining regions.
Avermectins (e.g., ivermectin) act as positive allosteric modulators and agonists that stabilize the open state of the channel, leading to persistent chloride influx and hyperpolarization. Phenylpyrazoles (e.g., fipronil) and isoxazolines (e.g., fluralaner) act as non-competitive antagonists that block the chloride pore, preventing inhibitory signaling and causing neuronal over-excitation.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutamate-gated chloride channel alpha (GluClα) (GluCl).